Golden Rice — Predicted 2026
AI-Predicted Question Angles for UPSC 2026
Comparative Analysis of GM Crop Regulation: India vs. Philippines
HighThe Philippines' approval of Golden Rice (2021) stands in stark contrast to India's continued cautious stance on GM crops. UPSC is keen on comparative policy analysis, especially within the Asian context. This angle allows for discussion on differing regulatory philosophies (precautionary principle vs. evidence-based), the role of public perception, political will, and the impact on food security strategies in both nations. Aspirants should be prepared to articulate the reasons behind each country's approach and their respective implications for agricultural biotechnology and public health outcomes. This also ties into broader discussions on science diplomacy and national sovereignty in technology adoption.
Golden Rice as a Model for Biofortification and its Contribution to SDGs
MediumWith the increasing global focus on achieving Sustainable Development Goals (SDGs), particularly SDG 2 (Zero Hunger) and SDG 3 (Good Health and Well-being), Golden Rice serves as a prime example of how biotechnology can directly contribute to these targets. Questions could explore its effectiveness as a food-based intervention for VAD, its sustainability compared to supplementation programs, and its potential to alleviate hidden hunger. This angle requires a nuanced understanding of its benefits, limitations, and the broader context of nutritional strategies, moving beyond just the GM controversy to its humanitarian impact. It also allows for discussion on other biofortified crops.
Ethical Dilemmas and Public Acceptance of Biotechnology: The Golden Rice Case
HighThe ethical debates surrounding Golden Rice—concerning its safety, environmental impact, IPR, and the 'technological fix' argument—remain highly relevant for UPSC Mains (GS-4 Ethics and Essay). Questions could probe the balance between scientific innovation and societal values, the role of activism (e.g., Greenpeace), and strategies for building public trust in biotechnology. This angle demands a critical examination of the various stakeholder perspectives and the challenges in communicating scientific consensus to the public. It's a classic example of science-society interface issues.